Aadi Bioscience, Inc. - Common Stock (AADI)

Investors were all spooked today with Dow plummeting more than 500 points. The primary cause can be attributed to inflation fears, disappointing earnings, and booming bond yields. Tech stocks drove the Dow down with the NASDAQ skidding 2.6 percent and the S&P 500 index falling 1.8 percent. The Dow closed down 1.5 percent. With the market selling off, it’s may very well be time to dive into biotech stocks currently trading at bargain prices. Some of the best value biotech stocks coupled with growth and momentum that needs to make the top of the Biotech Stock list include Brickell Biotech Inc (NASDAQ:BBI), Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Akebia Therapeutics Inc. (NASDAQ:AKBA), uniQure NV (NASDAQ:QURE), BioNTech SE (NASDAQ:BNTX), Seres Therapeutics Inc. (NASDAQ:MCRB), Marinus Pharmaceuticals Inc. (NASDAQ:MRNS), Aadi Bioscience Inc. (NASDAQ:AADI), Cassava Sciences Inc. (NASDAQ:SAVA). During the past year, biotech stocks, as represented by the iShares Biotechnology ETF (IBB), have posted a total return of -12.8%, significantly below the Russell 1000's total return of 21.0% as of Jan. 13, 2022. However, 2022 could very well be a turning point for the biotech charts to run up.